Association of anticoagulant use with clinical outcomes from crizotinib in ALK- and ROS1-rearranged advanced non-small cell lung cancers: A retrospective analysis of PROFILE 1001.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Association of anticoagulant use with clinical outcomes from crizotinib in ALK- and ROS1-rearranged advanced non-small cell lung cancers: A retrospective analysis of PROFILE 1001.

Ng TL, Tsui DCC, Wang S, Usari T, Patil T, Wilner K, Camidge DR. Association of anticoagulant use with clinical outcomes from crizotinib in ALK- and ROS1-rearranged advanced non-small cell lung cancers: A retrospective analysis of PROFILE 1001. Cancer Med. 2022 Dec; 11(23):4422-4429.

View in: PubMed

subject areas

Carcinoma, Non-Small-Cell Lung
Gene Rearrangement
Humans
Lung Neoplasms
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
Retrospective Studies

authors with profiles

David Ross Camidge
Tejas Patil

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium